Europe Pharmaceutical Blister Packaging Market Size (2024 - 2029)

The Europe Pharmaceutical Blister Packaging Market is anticipated to experience growth driven by the increasing demand for drug delivery solutions that ensure safety against external threats like contamination and counterfeiting. Factors such as the rising consumption of generic drugs, advancements in technology, and heightened health awareness are contributing to the expansion of the market. The region's robust pharmaceutical sector, characterized by significant R&D investments and a skilled workforce, presents opportunities for packaging vendors. Regulatory changes in the EU are also expected to boost the demand for blister packaging by facilitating faster access to generic medicines while encouraging the development of innovative drugs.

Market Size of Europe Pharmaceutical Blister Packaging Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Europe Pharmaceutical Blister Packaging Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 4.76 Billion
Market Size (2029) USD 6.61 Billion
CAGR (2024 - 2029) 6.77 %
Market Concentration Low

Major Players

Europe Pharmaceutical Blister Packaging Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Europe Pharmaceutical Blister Packaging Market Analysis

The Europe Pharmaceutical Blister Packaging Market size is estimated at USD 4.76 billion in 2024, and is expected to reach USD 6.61 billion by 2029, growing at a CAGR of 6.77% during the forecast period (2024-2029).

Pharmaceutical blister packaging plays a substantial role in ensuring the safety of drugs and medicine against unfavorable external influences such as biological contamination, counterfeiting, etc. The market is expected to grow due to the demand for drug delivery in blister packaging.

  • The rise in the consumption rate of generic drugs and the growth in the pharmaceutical sector in emerging economies are projected to influence the market's growth. Rapid technological advancements, a rise in health awareness, and the adoption of new regulatory standards drive the demand.
  • According to Flexible Packaging Europe, the first aspirins were made from aluminum foil in strip packaging. This foil material is used exclusively for blister packaging. Also, rising awareness regarding the importance of high-quality pharmaceutical packaging material, especially during transport and storage, is expected to drive market growth.
  • The pharmaceutical sector is one of the important industries for the United Kingdom, owing to the significant usage of drugs, improvement in medical science, and the increasing number of diseases in the country. The region's vital, well-established pharmaceutical sector comprises domestic companies and inward investors.
  • The market is expected to grow as the pharmaceutical sector is one of the significant engines of innovation and research. The sector is spending billions of dollars on R&D and employing vast numbers for highly skilled R&D roles. These massive investments and the proportion of skilled workers show how the region is building the pipeline of medicines and future drugs. This is an ideal opportunity for the packaging vendors. 
  • According to a study by Copenhagen Economics A/S in 2023, the EU pharmaceutical industry faced significant changes to the EU pharmaceutical legislation over the last two decades, impacting the incentives to develop and market orphan and non-orphan medicines. With the revision, the European Commission (EC) is offering measures to allow for faster access to generic medicines while at the same time incentivizing the continued development and introduction to the market of innovative medicines. Such changes would leverage the demand for blister packaging in the region.
  • According to the Organization for Economic Co-operation and Development (OECD), the pharmaceutical sector's costs and pricing structure are often indistinct, and there are legitimate inquiries about the degree of innovation and value offered by increasingly costly new treatments. Aluminum and plastic were used in pharmaceutical blister packaging. Over time, these materials became too expensive (due to raw material prices and other factors) to provide a commercially viable solution for packaging high-volume products.

Europe Pharmaceutical Blister Packaging Industry Segmentation

Blister packs allow the customers to keep track of doses of medicine with marked details and allow ease of storage for future purposes. Additionally, storing and handling the blister pack is convenient for commercial and household purposes, as the chances of damage are minimal.

The European pharmaceutical blister packaging market is segmented by material (plastic, paper, and aluminum), technology (cold forming and thermoforming), and country (the United Kingdom, Germany, Italy, France, Spain, and the Rest of Europe). The report offers market sizes and forecasts in terms of value (USD) for all the above segments.

By Material
Plastic
Paper
Aluminum
By Technology
Cold Forming
Thermoforming
By Country***
United Kingdom
Germany
Italy
France
Spain
Need A Different Region Or Segment?
Customize Now

Europe Pharmaceutical Blister Packaging Market Size Summary

The European pharmaceutical blister packaging market is poised for significant growth, driven by the increasing demand for drug delivery solutions that ensure the safety and integrity of pharmaceuticals. This market is characterized by its role in protecting medications from external factors such as biological contamination and counterfeiting. The sector is experiencing a surge in demand due to the rising consumption of generic drugs and the expansion of the pharmaceutical industry in emerging economies. Technological advancements, heightened health awareness, and the adoption of new regulatory standards are further propelling market growth. The UK's robust pharmaceutical sector, with its substantial investment in research and development, presents a lucrative opportunity for packaging vendors, as the region continues to innovate and expand its pipeline of medicines.

Sustainability is becoming a key focus in the European pharmaceutical blister packaging market, with manufacturers increasingly adopting eco-friendly materials and practices to meet consumer and regulatory demands. The shift towards sustainable packaging solutions, such as bio-based plastics and recyclable alternatives, is expected to drive market expansion. Initiatives like Aldi's blister pack recycling scheme and Boots Company's pilot recycling program highlight the growing consumer engagement in sustainability efforts. The market is also witnessing collaborations and innovations aimed at reducing environmental impact, such as the development of fiber-based blister packs and the use of post-consumer recycled content. These trends underscore the market's alignment with the increasing consumer preference for environmentally responsible packaging solutions.

Explore More

Europe Pharmaceutical Blister Packaging Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Market Overview

    2. 1.2 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.2.1 Bargaining Power Of Suppliers

      2. 1.2.2 Bargaining Power Of Buyers

      3. 1.2.3 Threat Of New Entrants

      4. 1.2.4 Threat Of Substitutes

      5. 1.2.5 Intensity Of Competitive Rivalry

    3. 1.3 Industry Value Chain Analysis

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Material

      1. 2.1.1 Plastic

      2. 2.1.2 Paper

      3. 2.1.3 Aluminum

    2. 2.2 By Technology

      1. 2.2.1 Cold Forming

      2. 2.2.2 Thermoforming

    3. 2.3 By Country***

      1. 2.3.1 United Kingdom

      2. 2.3.2 Germany

      3. 2.3.3 Italy

      4. 2.3.4 France

      5. 2.3.5 Spain

Europe Pharmaceutical Blister Packaging Market Size FAQs

The Europe Pharmaceutical Blister Packaging Market size is expected to reach USD 4.76 billion in 2024 and grow at a CAGR of 6.77% to reach USD 6.61 billion by 2029.

In 2024, the Europe Pharmaceutical Blister Packaging Market size is expected to reach USD 4.76 billion.

Europe Pharmaceutical Blister Packaging Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)